We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
-4.14%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.78B
AUM Growth
-$32.3M
(-1.2%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
3.71%
Top 10 Holdings %
Top 10 Hldgs %
12.19%
Holding
1,429
New
471
Increased
293
Reduced
210
Closed
447
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$45.7M |
| 2 |
Amgen
AMGN
|
+$38.7M |
| 3 |
Pfizer
PFE
|
+$34.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$32.8M |
| 5 |
Chevron
CVX
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$41.7M |
| 2 |
CELG
Celgene Corp
CELG
|
+$41.3M |
| 3 |
Micron Technology
MU
|
+$35M |
| 4 |
General Dynamics
GD
|
+$34.3M |
| 5 |
Altria Group
MO
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.47% |
| 2 | Healthcare | 13.96% |
| 3 | Industrials | 11.37% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Technology | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Mohawk Industries
MHK
$7.15B
| $397K | 0.01% |
+2,079
| New | +$385K |
|
|
ARMH
677
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $397K | 0.01% |
8,051
-17,609
| -69% | -$916K |
|
678
Karyopharm Therapeutics
KPTI
$158M
| $395K | 0.01% |
+968
| New | +$418K |
|
679
Banco Macro
BMA
$5.83B
| $394K | 0.01% |
8,646
+3,482
| +67% | +$185K |
|
680
Nokia
NOK
$49.9B
| $391K | 0.01% |
57,030
-106,314
| -65% | -$775K |
|
681
Northwest Bancshares
NWBI
$2.34B
| $391K | 0.01% |
30,535
-7,766
| -20% | -$95.7K |
|
682
Stepan Co
SCL
$1.32B
| $390K | 0.01% |
7,200
+671
| +10% | +$33.1K |
|
|
FTD
683
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $390K | 0.01% |
+13,838
| New | +$399K |
|
684
Nektar Therapeutics
NKTR
$2.36B
| $389K | 0.01% |
+2,073
| New | +$357K |
|
685
Axalta
AXTA
$7.64B
| $388K | 0.01% |
11,723
+753
| +7% | +$24.9K |
|
|
ESND
686
DELISTED
Essendant Inc.
ESND
| $384K | 0.01% |
9,783
+907
| +10% | +$36.7K |
|
687
John Wiley & Sons Class A
WLY
$2.73B
| $382K | 0.01% |
+7,026
| New | +$408K |
|
688
Prudential
PUK
$36.3B
| $379K | 0.01% |
+8,038
| New | +$390K |
|
689
Zurn Elkay Water Solutions
ZWS
$8.22B
| $377K | 0.01% |
+32,724
| New | +$411K |
|
690
Banner Corp
BANR
$2.39B
| $376K | 0.01% |
7,839
+1,400
| +22% | +$64.8K |
|
|
CMBT
691
CMB.TECH NV
CMBT
$4.46B
| $373K | 0.01% |
+25,175
| New | +$351K |
|
|
KAMN
692
DELISTED
Kaman Corp
KAMN
| $371K | 0.01% |
8,838
+634
| +8% | +$26.9K |
|
693
Western Alliance Bancorporation
WAL
$9.11B
| $369K | 0.01% |
10,941
-5,408
| -33% | -$172K |
|
|
AVID
694
DELISTED
Avid Technology Inc
AVID
| $365K | 0.01% |
27,345
+12,642
| +86% | +$202K |
|
695
Bio-Rad Laboratories Class A
BIO
$8.82B
| $362K | 0.01% |
2,404
-4,490
| -65% | -$642K |
|
696
Nu Skin
NUS
$254M
| $362K | 0.01% |
+7,676
| New | +$415K |
|
|
FNHC
697
DELISTED
FedNat Holding Company Common Stock
FNHC
| $362K | 0.01% |
+14,944
| New | +$406K |
|
698
Eagle Materials
EXP
$6.82B
| $360K | 0.01% |
+4,711
| New | +$389K |
|
699
GoPro
GPRO
$122M
| $360K | 0.01% |
+6,824
| New | +$351K |
|
|
PBPB
700
DELISTED
Potbelly
PBPB
| $360K | 0.01% |
+29,408
| New | +$413K |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Stevens Capital Management held 1,429 positions worth $2.78B, down 1.2% from $2.81B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Stevens Capital Management deployed $103M of net new capital in Q2 2015, opening 471 new positions and adding to 293 existing holdings. Its largest new stake was Verizon: 934,377 shares worth $43.6M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Altria Group, an estimated $27.8M trimmed.
- Stevens Capital Management's largest Q2 2015 buy was Verizon: 934,377 shares worth $43.6M.
- Stevens Capital Management added most to Amgen in Q2 2015, an estimated $38.7M increase.
- Stevens Capital Management's biggest Q2 2015 reduction was Altria Group, cutting an estimated $27.8M.
- Stevens Capital Management fully exited Procter & Gamble in Q2 2015, selling an estimated $41.7M.
- Stevens Capital Management's ten largest holdings make up 12% of its $2.78B portfolio in Q2 2015.
- Stevens Capital Management opened 471 new positions and closed 447 in Q2 2015.
- Stevens Capital Management's portfolio value fell 1.2% quarter-over-quarter to $2.78B.
Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.